6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01767129 (ClinicalTrials.gov)	July 2013	9/1/2013	Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Diseas ...	A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and ...	Dyskinesia;Parkinson's Disease	Drug: AVP-923-45;Drug: Placebo	Avanir Pharmaceuticals	Michael J. Fox Foundation for Parkinson's Research	Completed	30 Years	80 Years	All	14	Phase 2	United States;Canada
2	NCT00001365 (ClinicalTrials.gov)	July 1993	3/11/1999	Dextromethorphanfor the Treatment of Parkinson's Disease and Similar Conditions of the Nervous Syste ...	NMDA Receptor Antagonist Treatment of Neurodegenerative Disease	Neurodegenerative Disease;Parkinson's Disease	Drug: dextromethorphan	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	N/A	N/A	Both	42	Phase 2	United States

First Previous1Next Last